Clinical predictors of long-term outcomes in patients with critical limb ischemia (CLI) treated with endovascular therapy (EVT) remain unclear. In this study, clinical predictors of long-term outcomes in EVT-treated patients with CLI were investigated. In this prospective, observational study, we analyzed a total of 253 Taiwanese patients with CLI with 314 limbs who underwent EVT between 2005 and 2012. Cox models were used to estimate hazard ratios of death, limb loss, and sustained clinical success (SCS). Multivariate analysis showed that age, atrial fibrillation (AF), end-stage renal disease (ESRD), and albumin were significant predictors of mortality. Patients with coronary artery disease and low albumin levels had a significant risk of major limb amputation, while AF, ESRD, and albumin were significant, independent predictors of SCS. In addition to previously reported predictors, we showed that AF and malnutrition can be used to predict long-term outcome in EVT-treated patients with CLI.
SelvinEErlingerTP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National health and nutrition examination survey, 1999-2000. Circulation. 2004;110(6):738–743.
2.
NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFG.Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45suppl S:S5–S67.
3.
FallujiNMukherjeeD. Critical and acute limb ischemia: an overview. Angiology. 2014;65(2):137–146.
4.
NovoSCoppolaGMilioG. Critical limb ischemia: definition and natural history. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4(3):219–225.
5.
SawJBhattDLMoliternoDJ. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006;48(8):1567–1572.
6.
GolombBADangTTCriquiMH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114(7):688–699.
RollinsKEJacksonDCoughlinPA. Meta-analysis of contemporary short- and long-term mortality rates in patients diagnosed with critical leg ischaemia. Br J Surg. 2013;100(8):1002–1008.
9.
MarstonWADaviesSWArmstrongB. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg. 2006;44(1):108–114.
10.
LumsdenABDaviesMGPedenEK.Medical and endovascular management of critical limb ischemia. J Endovasc Ther. 2009;16(2 suppl 2):II31-II62.
11.
HuangHLChouHHWuTY. Endovascular intervention in Taiwanese patients with critical limb ischemia: patient outcomes in 333 consecutive limb procedures with a 3-year follow-up [published online 18 January 2013.]. J Formos Med Asso. 2013;112.
12.
DeRubertisBGFariesPLMcKinseyJF. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg. 2007;246(3):415–422.
13.
TennaASWatsonAStansbyG.Revascularization for critical limb ischemia in diabetes: surgery or angioplasty?. Angiology. 2014;65(4):272–273.
14.
YehKHTsaiYJHuangHLChouHHChangHJKoYL. Dual vascular access for critical limb ischemia: immediate and follow-up results. Catheter Cardiovasc Interv. 2011;77(2):296–302.
15.
BradburyAWAdamDJBellJ. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial. Health Technol Assess. 2010;14(14):1–210.
16.
SogaYMiiSAiharaH. Comparison of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia. Circ J. 2013;77(8):2102–2109.
17.
RomitiMAlbersMBrochado-NetoFCDurazzoAESPereiraCABDe LucciaN. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47(5):975–981.
18.
MarsoSPHiattWR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47(5):921–929.
19.
SilvestroAScopacasaFRuoccoA. Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vasc Med. 2003;8(4):225–232.
20.
BrevettiGSilvestroASchianoVChiarielloM. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108(17):2093–2098.
21.
O'Brien-IrrMSDosluogluHHHarrisLMDryjskiML. Outcomes after endovascular intervention for chronic critical limb ischemia. J Vasc Surg. 2011;53(6):1575–1581.
22.
ScaliSTBeckAWNolanBW. Completion duplex ultrasound predicts early graft thrombosis after crural bypass in patients with critical limb ischemia. J Vasc Surg. 2011;54(4):1006–1010.
23.
KohlerCHalbritterKStroszczynskiCMahlmannABeyer-WestendorfJWeissN. Determinants of intermediate term clinical outcome after endovascular below-knee interventions. Vasa. 2012;41(6):440–450.
24.
IidaOSogaYYamauchiY. Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions. J Vasc Surg. 2013;57(4):974–981e1.
25.
TaylorSM. Current status of heroic limb salvage for critical limb ischemia. Am Surg. 2008;74(4):275–284.
26.
SchanzerAMegaJMeadowsJSamsonRHBandykDFConteMS. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48(6):1464–1471.
27.
LoRCDarlingJBensleyRP. Outcomes following infrapopliteal angioplasty for critical limb ischemia. J Vasc Surg. 2013; 57(6):1455–1463.
28.
ConteMSGeraghtyPJBradburyAW.Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009;50(6):1462–1473e1-e3.
29.
SaqibNUDomenickNChoJS. Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia. J Vasc Surg. 2013;57(3):692–699.
30.
VirkkunenJHeikkinenMLepäntaloMMetsänojaRSaleniusJ-PGroupFS. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg. 2004;40(4):761–767.
31.
SuzukiKIidaOYamauchiY. Impact of diabetes mellitus on critical limb ischemia with below the knee disease: Japan below-the-knee artery treatment subanalysis [published online August 21, 2013]. Angiology. 2013. doi: 10.1177/0003319713499606
32.
IidaONakamuraMYamauchiY. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv. 2013;6(1):68–76.
33.
BiancariFSaleniusJ-PHeikkinenMLutherMYlönenKLepäntaloM. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg. 2007;31(1):217–225.
34.
O'HareAMFeinglassJSidawyAN. Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the department of veterans affairs' national surgical quality improvement program. J Am Soc Nephrol. 2003;14(5):1287–1295.
35.
O'HareAMBertenthalDSidawyANShlipakMGSenSChrenM-M. Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease. Clin J Am Soc Nephrol. 2006;1(2):297–304.
36.
MisseltAJZielinskiMDMedinaOI. Clinical outcomes after endovascular treatment of superficial femoral disease in patients with disabling claudication and critical limb ischemia: midterm analysis. Angiology. 2012;63(4):259–265.
37.
WinkelTAHoeksSESchoutenO. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Eur J Vasc Endovasc Surg. 2010;40(1):9–16.
38.
LaneJSMagnoCPLaneKTChanTHoytDBGreenfieldS. Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg. 2008;48(4):897–904.
39.
GalalWvan GestelYRHoeksSE. The obesity paradox in patients with peripheral arterial disease. Chest. 2008;134(5):925–930.
40.
BantaMRMaFBravataDMKirsnerRSFedermanDG. Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease. J Gen Intern Med. 2006;21(7):711–714.
41.
KumarBNGambhirRPS. Critical limb ischemia-need to look beyond limb salvage. Ann Vasc Surg. 2011;25(7):873–877.
